HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Köbel Selected Research

Endometrioid Carcinoma

1/2022Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.
11/2021Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
1/2021Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
11/2019Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
2/2019Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
1/2019Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma.
1/2019A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma.
8/2018Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas.
1/2018High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
2/2017Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Köbel Research Topics

Disease

76Neoplasms (Cancer)
11/2022 - 03/2002
68Carcinoma (Carcinomatosis)
06/2022 - 03/2002
22Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2008
20Endometrial Neoplasms (Endometrial Cancer)
07/2022 - 09/2008
20Endometrioid Carcinoma
01/2022 - 04/2006
8Adenocarcinoma
01/2022 - 01/2003
7Ovarian Epithelial Carcinoma
01/2021 - 02/2010
6Neoplasm Metastasis (Metastasis)
01/2022 - 04/2006
6Breast Neoplasms (Breast Cancer)
01/2021 - 06/2003
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2019 - 12/2009
3Endometriosis
01/2022 - 05/2017
3Sarcoma (Soft Tissue Sarcoma)
05/2021 - 08/2018
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 03/2013
3Residual Neoplasm
01/2020 - 04/2006
3Ascites
05/2012 - 03/2002
2Turcot syndrome
01/2022 - 01/2020
2Disease Progression
01/2021 - 07/2014
2Carcinogenesis
02/2020 - 08/2008
2Wilms Tumor (Wilm's Tumor)
01/2011 - 01/2009
1Neuroendocrine Carcinoma
07/2022
1Chromosomal Instability (Chromosome Stability)
01/2022
1Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
03/2021
1Leiomyosarcoma
01/2021
1Endometrial Stromal Sarcoma
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2020

Drug/Important Bio-Agent (IBA)

27Biomarkers (Surrogate Marker)IBA
03/2022 - 11/2007
26Proteins (Proteins, Gene)FDA Link
07/2022 - 03/2002
9PlatinumIBA
11/2022 - 05/2012
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2009
8Sucrose (Saccharose)IBA
07/2022 - 03/2016
8Estrogen ReceptorsIBA
01/2022 - 06/2003
8Biological ProductsIBA
01/2022 - 05/2010
7Exonucleases (3' 5' Exonuclease)IBA
01/2020 - 07/2014
7Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 10/2009
6Hormones (Hormone)IBA
06/2022 - 08/2013
6AntibodiesIBA
01/2022 - 03/2012
5MucinsIBA
01/2022 - 10/2011
5Eosine Yellowish-(YS) (Eosin)IBA
07/2020 - 04/2015
5ParaffinIBA
01/2017 - 04/2006
4RNA (Ribonucleic Acid)IBA
11/2022 - 04/2013
4Messenger RNA (mRNA)IBA
01/2022 - 03/2002
4CytokinesIBA
01/2021 - 05/2003
4Hematoxylin (Haematoxylon)IBA
04/2018 - 04/2015
3ChromatinIBA
01/2022 - 01/2018
3AntigensIBA
11/2020 - 01/2008
3Estrogens (Estrogen)FDA Link
01/2020 - 06/2016
3Carrier Proteins (Binding Protein)IBA
01/2019 - 03/2009
3Formaldehyde (Formol)FDA Link
01/2017 - 01/2013
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2004 - 03/2002
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2004 - 06/2003
2Phosphotransferases (Kinase)IBA
06/2022 - 01/2021
2taxaneIBA
04/2022 - 01/2021
2Cadherins (E-Cadherin)IBA
05/2021 - 07/2011
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 12/2009
2Coloring Agents (Dyes)IBA
01/2021 - 07/2020
2Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2020
2podocalyxinIBA
11/2020 - 03/2012
2Indicators and Reagents (Reagents)IBA
11/2020 - 08/2008
2Pharmaceutical PreparationsIBA
11/2020 - 11/2003
2EnzymesIBA
11/2020 - 03/2002
2VimentinIBA
11/2019 - 11/2015
2Transcription Factors (Transcription Factor)IBA
01/2019 - 02/2010
2Oral ContraceptivesIBA
05/2017 - 01/2009
2Fibronectins (Fibronectin)IBA
03/2012 - 01/2003
2Hepatocyte Nuclear FactorsIBA
01/2011 - 01/2009
2Insulin-Like PeptidesIBA
07/2010 - 03/2009
2Granzymes (Granzyme)IBA
07/2009 - 01/2008
2ezrinIBA
04/2006 - 04/2006
2TenascinIBA
01/2005 - 01/2003
2Protein Isoforms (Isoforms)IBA
11/2003 - 06/2003
2ProstaglandinsIBA
06/2003 - 03/2002
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
06/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2022
1SilverIBA
03/2022
1Letrozole (Femara)FDA LinkGeneric
01/2022
1Keratin-7 (Cytokeratin 7)IBA
05/2021
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
05/2021
1DNA Polymerase IIIBA
01/2021
1ChemokinesIBA
01/2021
1AndrogensIBA
01/2021
1Cyclin D1IBA
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2021
1TropomyosinIBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1Testosterone (Sustanon)FDA Link
01/2021
1Junctional Adhesion Molecule AIBA
11/2020
1Polysaccharides (Glycans)IBA
11/2020
1EpitopesIBA
11/2020
1GlypicansIBA
01/2020

Therapy/Procedure

30Therapeutics
11/2022 - 05/2003
16Drug Therapy (Chemotherapy)
04/2022 - 08/2008
8Neoadjuvant Therapy
04/2022 - 07/2011
4Adjuvant Chemotherapy
01/2021 - 03/2009
3Immunotherapy
11/2020 - 01/2017
3Chemoradiotherapy
01/2020 - 03/2013
3Tubal Sterilization (Tubal Ligation)
05/2017 - 01/2009
2Precision Medicine
03/2022 - 11/2015
2Radiotherapy
01/2022 - 01/2021
1Mastectomy (Mammectomy)
01/2022